ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Potassium Carbonate → 3-Butyl-8-chloro-1-{3-[3-(2,3-difluorobenzyl)-1,2,4-oxadiazol-5-yl]propyl}-3,7-dihydro-1H-purine-2,6-dione

HRID 1097656
印刷

反応式

HRID 1097656 の反応式
[F:1][C:2]1[C:7]([F:8])=[CH:6][CH:5]=[CH:4][C:3]=1[CH2:9][C:10]#[N:11].Cl.[NH2:13]O.C(=O)([O-])[O-].[K+].[K+].[CH2:21]([N:25]1[C:33]2[N:32]=[C:31]([Cl:34])[NH:30][C:29]=2[C:28](=[O:35])[N:27]([CH2:36][CH2:37][CH2:38][C:39](OCC)=[O:40])[C:26]1=[O:44])[CH2:22][CH2:23][CH3:24].[O-]CC.[Na+]>CCO.O>[CH2:21]([N:25]1[C:33]2[N:32]=[C:31]([Cl:34])[NH:30][C:29]=2[C:28](=[O:35])[N:27]([CH2:36][CH2:37][CH2:38][C:39]2[O:40][N:13]=[C:10]([CH2:9][C:3]3[CH:4]=[CH:5][CH:6]=[C:7]([F:8])[C:2]=3[F:1])[N:11]=2)[C:26]1=[O:44])[CH2:22][CH2:23][CH3:24]
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

8

反応物 5

HCID 11430Potassium CarbonateHCID 443297Hydroxyamine hydrochlorideHCID 5189682,3-DifluorophenylacetonitrileHCID 2723922Sodium ethoxideHCID 59395861Ethyl 4-(3-butyl-8-chloro-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)butanoate

生成物 1

HCID 59395685
3-Butyl-8-chloro-1-{3-[3-(2,3-difluorobenzyl)-1,2,4-oxadiazol-5-yl]propyl}-3,7-dihydro-1H-purine-2,6-dione
収率 22.6%

試薬・触媒・溶媒 2

HCID 702Ethanol溶媒2 回HCID 962Water溶媒

反応条件

温度
140 °C

実験手順

2,3-Difluorophenylacetonitrile (23 mg, 0.15 mmol) was dissolved in EtOH (1 ml). Hydroxylamine hydrochloride (14 mg, 0.20 mmol) was added, followed by water (0.5 ml) and potassium carbonate (41 mg, 0.3 mmol). The mixture was heated at reflux overnight and then cooled and partitioned between EtOAc and brine. The organic phase was evaporated and the crude amidoxime thus obtained was dissolved in EtOH (1 ml). Ethyl 4-(3-butyl-8-chloro-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)butanoate (43 mg, 0.12 mmol) and 21% by wt. ethanolic sodium ethoxide ((0.067 ml, 0.18 mmol) was added and the mixture heated in the microwave reactor at 140° C. for 10 min. The mixture was partitioned between EtOAc and 2M HCl, the organic phase evaporated and the product purified by MDAP to provide the title compound as a solid (13 mg).

後処理

  1. temperatureThe mixture was heated
  2. temperatureat reflux overnight
  3. temperaturecooled
  4. custompartitioned between EtOAc and brine
  5. customThe organic phase was evaporated
  6. customthe crude amidoxime thus obtained
  7. customThe mixture was partitioned between EtOAc and 2M HCl
  8. customthe organic phase evaporated
  9. customthe product purified by MDAP

出典と根拠

ORDレコード
ord-b079d49086ae41019873f7faac1e0528
出典データセット
uspto-grants-2012_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08143264B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート